1. Home
  2. ATLC vs DRUG Comparison

ATLC vs DRUG Comparison

Compare ATLC & DRUG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Atlanticus Holdings Corporation

ATLC

Atlanticus Holdings Corporation

HOLD

Current Price

$75.11

Market Cap

797.4M

Sector

Finance

ML Signal

HOLD

Logo Bright Minds Biosciences Inc.

DRUG

Bright Minds Biosciences Inc.

HOLD

Current Price

$82.56

Market Cap

707.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ATLC
DRUG
Founded
1996
2019
Country
United States
United States
Employees
576
N/A
Industry
Finance: Consumer Services
Pharmaceuticals and Biotechnology
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
797.4M
707.1M
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
ATLC
DRUG
Price
$75.11
$82.56
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
7
6
Target Price
$90.00
$129.25
AVG Volume (30 Days)
55.0K
159.1K
Earning Date
05-11-2026
05-15-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$477.21
N/A
Revenue Next Year
$10.42
N/A
P/E Ratio
$9.74
N/A
Revenue Growth
N/A
N/A
52 Week Low
$45.74
$23.18
52 Week High
$80.29
$123.75

Technical Indicators

Market Signals
Indicator
ATLC
DRUG
Relative Strength Index (RSI) 65.44 46.00
Support Level $48.94 $77.80
Resistance Level $78.91 $84.29
Average True Range (ATR) 3.27 3.99
MACD 0.13 -0.70
Stochastic Oscillator 71.56 12.84

Price Performance

Historical Comparison
ATLC
DRUG

About ATLC Atlanticus Holdings Corporation

Atlanticus Holdings Corp is a financial technology company powering more inclusive financial solutions for Everyday Americans. It provides technology and other support services to lenders who offer an array of financial products and services to consumers. The company's products and services are reported through two reportable segments. Credit as a Service (CaaS) offers products including private label credit cards using the Fortiva and Curae brand names as well as merchant-associated brands and Auto Finance provides purchase and/or service loans secured by automobiles from or for, and also provides floor-plan financing for, a pre-qualified network of independent automotive dealers and automotive finance companies in the buy-here, pay-here used car business.

About DRUG Bright Minds Biosciences Inc.

Bright Minds Biosciences Inc is focused on developing novel, transformative treatments for neuropsychiatric disorders, epilepsy, and pain. The company has a portfolio of next-generation serotonin agonists designed to target neurocircuit abnormalities that are responsible for difficult-to-treat disorders such as resistant epilepsy, treatment-resistant depression, PTSD, and pain. The company's drugs have been designed to potentially retain the powerful therapeutic aspects of psychedelic and other serotonergic compounds, while minimizing the side effects, thereby creating superior drugs to first-generation compounds, such as psilocybin.

Share on Social Networks: